Linda Stocum, Associate Editor

ICYMI, some of this week’s featured content includes an exclusive interview about tralokinumab, and articles on ruxolitinib as a treatment for vitiligo, the role of diet in acne and more.

Bayer is recalling its Lotrimin AF and Tinactin spray products due to the presence of the carcinogen benzene.

With increasing antibiotic resistance to treatment, impetigo research has been driven to find newer alternative options.

Researchers examine whether daylight PDT is less painful but equally as effective as conventional PDT as treatment for actinic keratosis.

The two companies are using their DREAM initiative to support the diverse dermatology index.

Arcutis Biotherapeutics, Inc has released data from its DERMIS-1 and DERMIS-2 Phase 3 pivotal studies demonstrating that the topical significantly reduced the burden and severity of itch.

In this exclusive video interview with Dermatology Times®, Andrew Blauvelt, MD, MBA, discusses the newest phase 3 clinical data on investigational tralokinumab as a potential treatment option in atopic dermatitis.

Amgen and Kyowa Kirin announce positive study data from their phase 2 trial of AMG 451/KHK4083.

Nemolizumab phase 2 clinical trial data for patients with prurigo nodularis and atopic dermatitis was recently released at the EADV.

This week’s edition of The Mainstream Patient features stories about skin cancer, a new app developed to diagnose skin issues, and more!

How are atopic dermatitis and out of pocket health care expenses related? This study aimed to find out.

A recent study in JAMA Dermatology investigated the possible association of atopic dermatitis and mental health outcomes across childhood.

ICYMI, some of this week’s featured content includes a new podcast episode on type 2 inflammation, and articles on Maui Derm NP+PA Fall 2021, the role of nutrition in wound care and more.

A study investigated the role diet habits have in the development, duration, and severity of acne.

Two published studies investigated the safety and efficacy of oral sarecycline for the treatment of truncal acne.

The Cosmetic Bootcamp is being held in Chicago, Illinois, December 11, 2021. The agenda for the event contains live patient demos and more.

Read this article to see what is being covered at the Science of Skincare annual meeting being held in New York, New York, on November 6, 2021.

A study published in the Journal of the American Academy of Dermatology did a subgroup analysis of ruxolitinib cream for vitiligo patients.

In this episode, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and more!

The 11th annual New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium agenda has been released. Click to see what this meeting has to offer.

The EADV has revealed the findings from a recent survey shows almost half of all European adults have a dermatological condition.

Data from a pilot study on a new prototype photodynamic therapy device for BCC was shown at the EADV Congress.

Two poster presentations at the EADV 30th annual conference showed the efficacy of roflumilast foam for nonsteroidal treatment of psoriasis or seborrheic dermatitis.

This week’s edition of The Mainstream Patient features stories about HS flares during the period, clothes that double as skincare, and more!

An article in the Plastic and Reconstructive Surgery journal investigates chronic wound care and the latest news in healing better and faster.

The investigation of the efficacy of moisturizing ceramide cream vs hydrophilic cream was published in the journal of Dermatologic Therapy.

Which is more worrisome, neonatal or infantile acne? An expert answered this question and more during Maui Derm NP+PA Fall 2021’s update on acne and rosacea.

A study in the Plastic and Reconstructive Surgery journal investigated the role of nutritional intervention in wound care.

ICYMI, some of this week’s featured content includes a new Pointers with Dr Portela, and articles on Maui Derm NP+PA coverage, website slander, nail issues plus more.

In this presentation on rosacea from Maui Derm NP+PA Fall 2021, Julie Harper, MD, explains why combination therapy is more effective and how classifying rosacea patients by subtype can lead to suboptimal treatments.